Pacemaker Implantation

Candidates include patients with symptomatic bradycardia documented in correlation with symptoms, complete (third-degree) AV block regardless of symptoms, second-degree Mobitz type II AV block, sick sinus syndrome with documented symptomatic episodes, symptomatic chronotropic incompetence, and tachy-brady syndrome requiring rate control medication. Contraindications include reversible causes of bradycardia such as medication effects that can be discontinued, electrolyte imbalance, or hypothyroidism. Your cardiologist will evaluate your specific condition against established guidelines.

Several device variants exist: Single-chamber (VVI) for chronic atrial fibrillation with slow ventricular rate; Dual-chamber (DDD) for AV block or sinus node dysfunction requiring AV synchrony; Biventricular (CRT-P) for heart failure patients with conduction delay and pacing indication; Leadless pacemakers (Micra, AVEIR) placed entirely within the heart via femoral vein without chest incision or leads; and Conduction system pacing (His-bundle or left bundle branch area pacing) for more physiologic activation. Device selection depends on your specific condition and pacing requirements.

Most patients are discharged the same day or within 1 day. Arm movement on the implant side is restricted for 4-6 weeks to allow lead settling. Light walking is encouraged immediately, with return to sedentary work typically at 3-5 days, driving at 1 week (private vehicle), and full normal activities by 6 weeks. Leadless pacemakers have no arm restrictions and faster recovery.

For uncomplicated pacemaker implantation, a minimum stay of 2-3 weeks in Thailand is recommended. Commercial flying is safe once pneumothorax has been excluded by imaging and the first follow-up device check is satisfactory. The pacemaker itself is unaffected by cabin pressure or altitude — the underlying cardiac condition is the primary determinant of fitness to fly. Your cardiologist will provide written clearance based on your clinical status.

Thailand's all-inclusive pacemaker packages at JCI-accredited hospitals range from $8,000-$14,500, compared to typical US costs of $20,000-$50,000 (varying significantly by device type, insurance status, and region). Even including travel and accommodation costs of $1,500-$3,000, uninsured or high-deductible patients typically see net savings of 50-75%. Device cost represents 50-70% of total US procedural cost; Thailand pricing includes the device.

Modern pacemaker batteries last 7-15 years depending on device type and pacing burden: single-chamber devices typically last 10-15 years, dual-chamber 8-12 years, and CRT-P 6-10 years. Leadless pacemakers (Micra VR2) have projected longevity of 16-17 years. Battery status is monitored remotely and during clinic visits. When the Elective Replacement Indicator is reached, a generator replacement is scheduled — a simpler 20-45 minute procedure under local anesthesia that reuses existing leads.

Leadless pacemakers are self-contained devices implanted directly into the heart via a catheter through the femoral vein, eliminating the need for chest incision, subcutaneous pocket, and transvenous leads. This eliminates lead-related and pocket-related complications including infection, lead fracture, and pneumothorax. Current leadless options include single-chamber (Micra VR) and newer dual-chamber systems (AVEIR DR). Candidates typically include patients requiring single-chamber ventricular pacing, those with prior device infections, or patients with vascular access limitations.

All current-generation pacemakers from major manufacturers are MRI-conditional, meaning MRI scanning is cleared at 6 or more weeks post-implant with appropriate device reprogramming before and after the scan. Most devices are approved for 1.5T full-body scanning, with some newer devices approved for 3T. Exclusions include abandoned leads, devices at end-of-life, and non-conditional system components. Your care team will confirm MRI compatibility and coordinate programming.

Most patients resume full normal activities within 6 weeks. You should carry your device identification card, avoid prolonged close contact with strong magnets (maintain 15 cm distance), use your cell phone on the opposite ear from the device, and inform all healthcare providers and airport security personnel. Most non-contact sports are permitted after full recovery. Walk through airport metal detectors at normal pace — they will not affect device function.

Follow-up includes wound check at 7-14 days, comprehensive device interrogation at 4-6 weeks, in-clinic checks every 6-12 months, and automated remote monitoring transmissions every 3-6 months. Remote monitoring reduces office visits while providing early detection of lead issues, arrhythmias, and battery status changes. All major manufacturers offer remote monitoring platforms compatible worldwide.